JP2018526399A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526399A5 JP2018526399A5 JP2018512339A JP2018512339A JP2018526399A5 JP 2018526399 A5 JP2018526399 A5 JP 2018526399A5 JP 2018512339 A JP2018512339 A JP 2018512339A JP 2018512339 A JP2018512339 A JP 2018512339A JP 2018526399 A5 JP2018526399 A5 JP 2018526399A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- nhc
- heteroaryl
- nhs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 95
- 125000003118 aryl group Chemical group 0.000 claims 57
- 125000001072 heteroaryl group Chemical group 0.000 claims 41
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 40
- 150000001875 compounds Chemical class 0.000 claims 24
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 16
- 125000005843 halogen group Chemical group 0.000 claims 15
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 14
- 125000000623 heterocyclic group Chemical group 0.000 claims 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 11
- -1 -NC Chemical group 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 125000001188 haloalkyl group Chemical group 0.000 claims 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 6
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 4
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 125000005358 mercaptoalkyl group Chemical group 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 3
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 230000002159 abnormal effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 102100037839 Acidic mammalian chitinase Human genes 0.000 claims 1
- 101710178876 Acidic mammalian chitinase Proteins 0.000 claims 1
- 208000030090 Acute Disease Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 102100037328 Chitotriosidase-1 Human genes 0.000 claims 1
- 208000018035 Dental disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 208000014151 Stomatognathic disease Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 125000000732 arylene group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 108010057052 chitotriosidase Proteins 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 1
- 208000016097 disease of metabolism Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000003176 fibrotic effect Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021050972A JP2021100966A (ja) | 2015-09-04 | 2021-03-25 | ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562214299P | 2015-09-04 | 2015-09-04 | |
| US62/214,299 | 2015-09-04 | ||
| PL415078A PL415078A1 (pl) | 2015-09-04 | 2015-12-04 | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
| PLP.415078 | 2015-12-04 | ||
| PCT/IB2016/055269 WO2017037670A1 (en) | 2015-09-04 | 2016-09-02 | Substituted amino triazoles useful as human chitinase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021050972A Division JP2021100966A (ja) | 2015-09-04 | 2021-03-25 | ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018526399A JP2018526399A (ja) | 2018-09-13 |
| JP2018526399A5 true JP2018526399A5 (https=) | 2019-10-10 |
| JP6859325B2 JP6859325B2 (ja) | 2021-04-14 |
Family
ID=58190067
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018512339A Active JP6859325B2 (ja) | 2015-09-04 | 2016-09-02 | ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール |
| JP2021050972A Pending JP2021100966A (ja) | 2015-09-04 | 2021-03-25 | ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021050972A Pending JP2021100966A (ja) | 2015-09-04 | 2021-03-25 | ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US9944624B2 (https=) |
| EP (1) | EP3344616B1 (https=) |
| JP (2) | JP6859325B2 (https=) |
| KR (1) | KR102699408B1 (https=) |
| CN (1) | CN108290863B (https=) |
| AU (1) | AU2016314345B2 (https=) |
| CA (1) | CA2997382C (https=) |
| CL (1) | CL2018000564A1 (https=) |
| CO (1) | CO2018003484A2 (https=) |
| CY (1) | CY1121432T1 (https=) |
| DK (1) | DK3344616T3 (https=) |
| ES (1) | ES2717181T3 (https=) |
| HK (1) | HK1249510B (https=) |
| HR (1) | HRP20190223T1 (https=) |
| HU (1) | HUE042726T2 (https=) |
| IL (1) | IL257545B (https=) |
| LT (1) | LT3344616T (https=) |
| ME (1) | ME03308B (https=) |
| MX (1) | MX368674B (https=) |
| PE (1) | PE20181048A1 (https=) |
| PH (1) | PH12018500286A1 (https=) |
| PL (2) | PL415078A1 (https=) |
| PT (1) | PT3344616T (https=) |
| SA (1) | SA518391033B1 (https=) |
| SI (1) | SI3344616T1 (https=) |
| SM (1) | SMT201900172T1 (https=) |
| TR (1) | TR201903826T4 (https=) |
| WO (1) | WO2017037670A1 (https=) |
| ZA (1) | ZA201801978B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN09346A (https=) | 2012-06-13 | 2015-07-17 | Hoffmann La Roche | |
| KR102179599B1 (ko) | 2012-09-25 | 2020-11-19 | 에프. 호프만-라 로슈 아게 | 이환형 유도체 |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| CN105764905B (zh) | 2013-11-26 | 2019-06-07 | 豪夫迈·罗氏有限公司 | 新的八氢-环丁二烯并[1，2-c；3，4-c’]二吡咯-2基 |
| WO2015144609A1 (en) | 2014-03-26 | 2015-10-01 | F. Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| CN106103446B (zh) | 2014-03-26 | 2019-07-30 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物 |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| CA2992889A1 (en) | 2015-09-04 | 2017-03-09 | F. Hoffmann-La Roche Ag | Phenoxymethyl derivatives |
| PL415078A1 (pl) | 2015-09-04 | 2017-03-13 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
| AU2016328365B2 (en) | 2015-09-24 | 2020-04-23 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
| KR20180054830A (ko) | 2015-09-24 | 2018-05-24 | 에프. 호프만-라 로슈 아게 | 오토탁신(atx) 억제제로서의 이환형 화합물 |
| RU2018112230A (ru) | 2015-09-24 | 2019-10-30 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов atx |
| CR20180057A (es) | 2015-09-24 | 2018-04-02 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca. |
| SG11201908560SA (en) | 2017-03-16 | 2019-10-30 | Hoffmann La Roche | Heterocyclic compounds useful as dual atx/ca inhibitors |
| WO2018167113A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | New bicyclic compounds as atx inhibitors |
| CN109503449A (zh) * | 2018-12-17 | 2019-03-22 | 天津药明康德新药开发有限公司 | 一种3-硝基吖丁啶-1-甲酸叔丁酯的合成方法 |
| AU2020313312A1 (en) | 2019-07-15 | 2022-03-03 | Oncoarendi Therapeutics S.A. | Substituted amino triazoles useful as chitinase inhibitors |
| IL291569B2 (en) * | 2019-09-25 | 2025-04-01 | Oncoarendi Therapeutics Sa | Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-4,2,1-triazol-3-amine |
| EP3854789A1 (en) | 2020-01-22 | 2021-07-28 | Cygnet Biosciences B.V. | Macrocyclic compounds useful as chitinase inhibitors |
| CN114057714B (zh) * | 2021-11-22 | 2023-07-14 | 苏州健雄职业技术学院 | 杂环基取代的氨基三唑的衍生物及其应用 |
| US12325701B2 (en) * | 2022-03-04 | 2025-06-10 | Molecure S.A. | YKL-40 inhibitors and their therapeutic |
| CN116924985B (zh) * | 2022-03-29 | 2026-03-17 | 山东新时代药业有限公司 | 一种法舒地尔的制备方法 |
| EP4269400B1 (en) * | 2022-04-29 | 2025-07-09 | Molecure SA | Ykl-40 inhibitors and their therapeutic applications |
| CN114957098B (zh) * | 2022-06-02 | 2024-03-29 | 和鼎（南京）医药技术有限公司 | 一种制备喷他佐辛中间体的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU643141B2 (en) | 1991-03-15 | 1993-11-04 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| SG11201605757SA (en) | 2013-12-20 | 2016-08-30 | Inst Drug Discovery | Substituted amino triazoles, and methods using same |
| US9440953B2 (en) * | 2014-12-19 | 2016-09-13 | OncoArendi Therapeutics Sp. z o.o. | Substituted amino triazoles useful as acidic mammalian chitinase inhibitors |
| PL415078A1 (pl) | 2015-09-04 | 2017-03-13 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków |
-
2015
- 2015-12-04 PL PL415078A patent/PL415078A1/pl unknown
-
2016
- 2016-09-02 TR TR2019/03826T patent/TR201903826T4/tr unknown
- 2016-09-02 PE PE2018000314A patent/PE20181048A1/es unknown
- 2016-09-02 AU AU2016314345A patent/AU2016314345B2/en active Active
- 2016-09-02 HR HRP20190223TT patent/HRP20190223T1/hr unknown
- 2016-09-02 WO PCT/IB2016/055269 patent/WO2017037670A1/en not_active Ceased
- 2016-09-02 EP EP16767368.0A patent/EP3344616B1/en active Active
- 2016-09-02 SI SI201630168T patent/SI3344616T1/sl unknown
- 2016-09-02 KR KR1020187009490A patent/KR102699408B1/ko active Active
- 2016-09-02 CA CA2997382A patent/CA2997382C/en active Active
- 2016-09-02 MX MX2018002659A patent/MX368674B/es active IP Right Grant
- 2016-09-02 HK HK18109046.5A patent/HK1249510B/en unknown
- 2016-09-02 SM SM20190172T patent/SMT201900172T1/it unknown
- 2016-09-02 DK DK16767368.0T patent/DK3344616T3/en active
- 2016-09-02 CN CN201680062288.2A patent/CN108290863B/zh active Active
- 2016-09-02 JP JP2018512339A patent/JP6859325B2/ja active Active
- 2016-09-02 PL PL16767368T patent/PL3344616T3/pl unknown
- 2016-09-02 LT LTEP16767368.0T patent/LT3344616T/lt unknown
- 2016-09-02 PT PT16767368T patent/PT3344616T/pt unknown
- 2016-09-02 ES ES16767368T patent/ES2717181T3/es active Active
- 2016-09-02 US US15/255,226 patent/US9944624B2/en active Active
- 2016-09-02 ME MEP-2019-33A patent/ME03308B/me unknown
- 2016-09-02 HU HUE16767368A patent/HUE042726T2/hu unknown
-
2018
- 2018-02-08 PH PH12018500286A patent/PH12018500286A1/en unknown
- 2018-02-15 IL IL257545A patent/IL257545B/en active IP Right Grant
- 2018-02-28 US US15/908,249 patent/US10208020B2/en active Active
- 2018-02-28 SA SA518391033A patent/SA518391033B1/ar unknown
- 2018-03-01 CL CL2018000564A patent/CL2018000564A1/es unknown
- 2018-03-26 ZA ZA2018/01978A patent/ZA201801978B/en unknown
- 2018-03-29 CO CONC2018/0003484A patent/CO2018003484A2/es unknown
-
2019
- 2019-02-15 US US16/277,321 patent/US10538508B2/en active Active
- 2019-03-15 CY CY20191100310T patent/CY1121432T1/el unknown
-
2021
- 2021-03-25 JP JP2021050972A patent/JP2021100966A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018526399A5 (https=) | ||
| IL257545A (en) | Transformed amino triazoles are useful as human cytinase inhibitors | |
| JP2013532652A5 (https=) | ||
| JP2010510237A5 (https=) | ||
| JP2019518766A5 (https=) | ||
| JP2019094345A5 (https=) | ||
| JP2013500314A5 (https=) | ||
| JP2020502047A5 (https=) | ||
| JPWO2020123827A5 (https=) | ||
| CR20200418A (es) | Inhibidores de orginasa y sus mètodos de uso antecedentes | |
| JP2002524463A5 (https=) | ||
| JP2018516963A5 (https=) | ||
| JP2009507896A5 (https=) | ||
| JP2013510825A5 (https=) | ||
| JP2019500387A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2019535723A5 (https=) | ||
| IL287159B1 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| CN115697992A (zh) | 一种能够抑制并降解雄激素受体的化合物及其药物组合物和药学上的应用 | |
| JP2009539943A5 (https=) | ||
| RU2006124856A (ru) | Гидронопольные производные в качестве агонистов по отношению к orl1 рецепторам человека | |
| JP2022119852A5 (https=) | ||
| JP2006516626A5 (https=) | ||
| JP2017532294A5 (https=) | ||
| JP2018536678A5 (https=) |